When Don Kerrigan, a well-versed executive previously serving as the president of Nature’s Bounty, was appointed to be the CEO of Nestlé Health Science U.S. in 2021 as a result of the acquisition of the global nutrition player, he had an ambitious vision for the business — finding more scalable opportunities in CPG sectors where the Swiss conglomerate doesn’t traditionally have a foothold.

When Don Kerrigan, a well-versed executive previously serving as the president of Nature’s Bounty, was appointed to be the CEO of Nestlé Health Science U.S. in 2021 as a result of the acquisition of the global nutrition player, he had an ambitious vision for the business — finding more scalable opportunities in CPG sectors where the Swiss conglomerate doesn’t traditionally have a foothold.

With a growing number of health-focused products available on the market driven by consumers prioritizing food as medicine, Nestlé Health Science has quickly capitalized on the trend, onboarding a handful of better-for-you grocery brands over the years, notably Dr. Andrew Abraham-founded Orgain and Vital Proteins. This portfolio expansion resonates with Kerrigan personally.

Read More